Colorectal cancer often involves dysregulation of the mTOR pathway, leading to activation of the AKT/mTOR axis and increased expression of c-Myc and HIF-1α; the former promotes glycolysis, and the latter accelerates the metabolic rate in colon cancer cells 92. The gene discussed is MYC; the disease is colorectal cancer.